State Street’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Buy |
66,451
+1,235
| +2% | +$2.78K | ﹤0.01% | 3896 |
|
|
2025
Q1 | $140K | Buy |
65,216
+4,398
| +7% | +$9.41K | ﹤0.01% | 3899 |
|
|
2024
Q4 | $147K | Buy |
60,818
+762
| +1% | +$1.84K | ﹤0.01% | 3913 |
|
|
2024
Q3 | $147K | Buy |
60,056
+796
| +1% | +$1.94K | ﹤0.01% | 3893 |
|
|
2024
Q2 | $152K | Buy |
59,260
+1,128
| +2% | +$2.9K | ﹤0.01% | 3895 |
|
|
2024
Q1 | $170K | Buy |
58,132
+158
| +0.3% | +$461 | ﹤0.01% | 3910 |
|
|
2023
Q4 | $134K | Buy |
57,974
+1,160
| +2% | +$2.68K | ﹤0.01% | 3988 |
|
|
2023
Q3 | $148K | Buy |
56,814
+1,512
| +3% | +$3.95K | ﹤0.01% | 4008 |
|
|
2023
Q2 | $198K | Buy |
55,302
+1,436
| +3% | +$5.14K | ﹤0.01% | 4015 |
|
|
2023
Q1 | $117K | Buy |
53,866
+2,873
| +6% | +$6.26K | ﹤0.01% | 4268 |
|
|
2022
Q4 | $613K | Buy |
50,993
+4,001
| +9% | +$48.1K | ﹤0.01% | 3694 |
|
|
2022
Q3 | $305K | Buy |
46,992
+983
| +2% | +$6.38K | ﹤0.01% | 3965 |
|
|
2022
Q2 | $211K | Sell |
46,009
-491,661
| -91% | -$2.25M | ﹤0.01% | 4173 |
|
|
2022
Q1 | $4.65M | Buy |
537,670
+25,424
| +5% | +$220K | ﹤0.01% | 3219 |
|
|
2021
Q4 | $7.32M | Buy |
512,246
+24,247
| +5% | +$346K | ﹤0.01% | 3064 |
|
|
2021
Q3 | $10.7M | Buy |
487,999
+136,079
| +39% | +$2.99M | ﹤0.01% | 2852 |
|
|
2021
Q2 | $4.71M | Buy |
+351,920
| New | +$4.71M | ﹤0.01% | 3280 |
|